Recessive RPE65-associated retinal dystrophy (RPE65-RD) is thought to account for approximately 5% to 10% of LCA and 1% to 2% of retinitis pigmentosa, and successful gene replacement has been demonstrated in phase I/II and III clinical trials.2 The gene discussed is RPE65; the disease is retinitis pigmentosa.